Home | About CytoJournalEditorial Board | Archived articles | Search CytoJ Articles | Subscribe | Peer review policies | CytoJournal Quiz Cases
  Reviewer corner | Author corner | OA Steward’s corner | CF member’s corner | Join as CF member | Manuscript submission | Open Access (OA) Advocacy
CytoJournal All 'FULL TEXT' in HTML are
FREE under "open access"
charter of CytoJournal.
Click here To login for
downloading any PDF OR to
request TOC (Table of Content)
by e-mail
Home Email this page Print this page Small font size Default font size Increase font size Cytopathology Foundation
Navigate Here
  »  Click here to download PDF's of additional articles 
  »   Apply as Referee
  »   Common difficulties (FAQ)
  »   Article Publication Charge (FAQ)
  »   Reference style (PPS)



Submit articles
Email alerts
Join us
Most popular articles

    » Instructions for CytoJournal authors
 

General InformationSubmission checklistPublication and peer review processes |  Editorial policies  |  Preparing main manuscript text  |  Competing interests


 

»» General information Top

 

Technical support for online submission difficulty: techsupportsupport @ medknow . com
Editorial support with academic questions and other queries: cytojournal @ cytojournal . com

Submission process

Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf (except in rare cases by the editorial office at the request of the submitting author in rare cases for unforeseen reasons after due documentation). The submitting author takes responsibility for the article during submission and peer review.

To facilitate rapid publication and to minimize administrative costs, CytoJournal accepts only online submission. The submission process is compatible with version 5.5 or later of Internet Explorer and Netscape Navigator, and with most other modern web browsers. It can be used from PC, Mac, or Unix platforms.

Files can be submitted as a batch, or one by one. The submission process can be interrupted at any time - when users return to the site, they can carry on where they left off.

See below for examples of acceptable word processor and graphics file formats. Additional files of any type, such as movies, animations, or original data files, can also be submitted as part of the publication.

Please refer to Submission checklist

»» Submission checklist Top

Please check the following points before proceeding.

1. Manuscript files

Do you have all the files for the manuscript in an acceptable format?

Main manuscript

Manuscript is split in to the following parts (steps):

 a. First page file [First page template (Research)] [First page template (Case Report)]

·         Use text/rtf/doc/pdf file (Max size 100 KB). This should include the following:

·         The title of the article. The title should be catchy and intuitive about the article topic. It should preferably include the study design.

·         Author details: The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page.

·         The details of corresponding author should include- e-mail address, mailing address, phone & fax numbers (country & area code).

·         Other statements- Conflict of Interest statement, authorship statement, Acknowledgement(s) (if any) (see first page templates).

(Any other details unrelated to the actual article and may have author / institution identification)

b. Article file  [Manuscript template (Research)] [Manuscript template (Case Report)]

·         Use text/rtf/doc/pdf file (Max size 400 KB)  Should contain the Title and text from abstract onwards.

No information which can reveal contributors' identity should be included in this file (e.g. acknowledgement).

The automatic online review system sends only ‘article file’ to the reviewers without any author details.

c. Figure/video files (must be separate files and should NOT be embedded in the main manuscript).

Each figure should be a separate file. Sketches, different diagrams including bar diagrams and pie charts, algorithms, and flow charts should be submitted as figures. DONOT submit tables with columns and rows as figures.

·         IMAGES: Formats: PNG, TIFF (for photographs and screen dumps), JPEG. ·         FIGURES: Formats PPT ·         VIDEOS: Formats mpg, mpeg, mp4, wmv

CME questions: Some type of articles (research articles, methodology articles, case reports, quiz cases, review articles, and Cytojournal monograph articles) require at least 3 multiple choice questions for CME. For general guidelines, please use the following manual available free online:

Constructing Written Test Questions For the Basic and Clinical Sciences http://www.nbme.org/PDF/ItemWriting_2003/2003IWGwhole.pdf

2. Suggest reviewers: You will have opportunity to suggest reviewers at the end of the manuscript submission.

Please suggest particularly qualified reviewers who have had experience in the subject of the submitted manuscript, but who are not affiliated with the same institutes as the contributor/s. CytoJournal peer-review system may or may not include the suggested peer-reviewer depending on reviewer availability and editor decision. The reviewer may be included in the core peer-reviewer list for future other manuscripts on similar topics.

Please keep their names and e-mail addresses ready to copy-paste.

3. Article Publication Charge (APC)

Journal DOES NOT charge for manuscript submission.
However, if the manuscript is accepted after ‘double blind’ review process CytoJournal charges ‘Article Publication Charge’ (APC) of $ 1500 for publishing the final version.
APC is waived totally for all Cytopathology Foundation (CF) members in good standing at least for 30 days (for any number of manuscripts). The date of accepting the manuscript for publication (NOT the date of submission) is considered for calculating this minimum period of 30 days requirement.
For additional benefits to CF members, please visit CF member’s corner at http://www.cytojournal.com/CFMember.asp

4. Are you one of the authors of this article?

If not, you cannot submit the article on behalf of the authors. The submitting author takes responsibility for the article during submission and peer review.

5. Conditions of submission and CytoJournal Copyright and License Agreement

Do you confirm that all the authors of the manuscript have read and agreed to its content, that readily reproducible materials described in the manuscript will be freely available to any scientist wishing to use them for non-commercial purposes , and that you have ethical approval for any human or animal experimentation (for more information see our Instructions for Authors)? Do you confirm that the manuscript is original, has not already been published in a journal and is not currently under consideration by another journal? To read the terms of the CytoJournal Copyright and License Agreement, please click this link.

»» Publication and peer review processes Top

Peer review policies

Click here to read

Publication

Once an article is accepted, it is published in CytoJournal. The article will be published in both fully browseable web form (HTML), and as a formatted PDF. Tthe HTML of the article will then be available through CytoJournal and PubMed Central, and will also be included in PubMed.

Article Publication Charge (APC)
 

Journal DOES NOT charge for manuscript submission.

However, if the manuscript is accepted after ‘double blind’ review process CytoJournal charges ‘Article Publication Charge’ (APC) of $ 1500 for publishing the final version.

 

APC is waived totally for all Cytopathology Foundation (CF) members in good standing at least for 30 days (for any number of manuscripts). The date of accepting the manuscript for publication (NOT the date of submission) is considered for calculating this minimum period of 30 days requirement.

For additional benefits to CF members, please visit CF member’s corner at http://www.cytojournal.com/CFMember.asp

APC is waived for following:

1.     Cytopathology Foundation (CF) members. Please click here to become CF member (US $ 50 / year OR US $ 1000 for life)

2.     All members of organizations/societies/and other entities as ‘CytoJ OA Stewards-Plus’. Please click here to check if your society-organization is ‘CytoJ OA Stewards-Plus’

APC is subsidized to US$ 500 for following:

All members of organizations/societies/and other entities identified as and included in the list of ‘CytoJ OA Stewards’, get partial but significant waiver ($500 instead of $1500). Please click here to check if your society-organization is ‘CytoJ OA Stewards’ without any financial obligation to it.

APC may also be waived or subsidized to:
Group with reasonable proof of financial hardship to afford any of the pathways shown above.

Waivers may be granted, particularly for authors from countries / institutions with financial hardship. For further details, see more information about article publication charges

»» Editorial policies Top

Any manuscript submitted to CytoJournal must not already have been published in another journal or be under consideration by any other journal.

Manuscripts must not have already been published in any journal or other citable form, with the exception that the journal is willing to consider peer-reviewing manuscripts that are translations of articles originally published in another language. In this case, the consent of the journal in which the article was originally published must be obtained and the fact that the article has already been published must be made clear on submission and stated in the abstract.

Manuscripts that are derived from papers presented at conferences may be submitted unless they have already been published as part of the conference proceedings in a peer reviewed journal. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. Authors who publish in CytoJournal retain copyright to their work (more information http://creativecommons.org/licenses/by/2.0/ ); however. They agree to share it in public domain for non-commercial purposes. The royalties earned from commercial use may be shared through www.copyright.com. Correspondence concerning articles published in CytoJournal is encouraged.

Guideline for duplicate publication as flowchart is at COPE:
http://www.publicationethics.org.uk/flow-charts/cope-flowcharts-optimal.pdf/view


Submission of a manuscript to CytoJournal implies that all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee and Institutional Review Board (IRB) or its counterpart as indicated by local policies, standards, and laws.

Research carried out on humans must be in compliance with the Helsinki Declaration http://www.wma.net/en/30publications/10policies/b3/  , and any experimental research on animals must follow internationally recognized guidelines. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body which gave approval, with a reference number where appropriate. Informed consent must also be documented. Manuscripts may be rejected if the editorial office considers that the research has not been carried out within an ethical framework, e.g. if the severity of the experimental procedure is not justified by the value of the knowledge gained.

Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Methods section.

Authors of CytoJournal articles complete a declaration of competing interests, which is provided as a separate section of the manuscript as part of first page file. This information is included in the finally published version, if the manuscript is accepted for publication.

Competing interests

A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.

Authors are required to complete a declaration of competing interests. The information on competing interests will be included in the published articles.

When completing your declaration, please consider the following questions:

Financial competing interests

·         In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.

·         Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.

·         Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.

·         Do you have any other financial competing interests? If so, please specify.

Non-financial competing interests

Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify.
If you are unsure as to whether you, or one your co-authors, has a competing interest please discuss it with the editorial office.

In the absence of competing interests, the declaration may read 'The author(s) declare that they do not have competing interests'. Much has been written about competing interests (or conflict of interest, as other journals call it) within scientific research, but the following articles provide some background:

R Smith: Beyond conflict of interest. BMJ 1998, 317 :291-292

R Smith: Making progress with competing interests. BMJ 2002, 325 :1375-1376

CD DeAngelis, PB Fontanarosa, A Flanagin: Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001, 286 :89-9

K Morin, H Rakatansky, FA Riddick Jr, LJ Morse, JM O'Bannon 3rd, MS Goldrich, P Ray, M Weiss, RM Sade, MA Spillman: Managing conflicts of interest in the conduct of clinical trials. JAMA 2002, 287 :78-84

For all articles that include patients identifiable information or clinical photographs relating to individual patients, written and signed consent from each patient to publish must also be mailed or faxed to the editorial staff. The manuscript should also include a statement to this effect in the Acknowledgements section, as follows: "Written consent for publication was obtained from the patient or their relative."

CytoJournal supports initiatives to improve the performance and reporting of clinical trials, part of which includes prospective registering and numbering of trials. While there are initiatives to ensure that all clinical trials are registered (most notably the recent statement from the International Committee of Medical Journal Editors - see http://www.icmje.org/about-icmje/ ), we are focusing on controlled trials of healthcare interventions, for now. Authors of protocols or reports of controlled trials of health care interventions must register their trial prior to submission in a suitable publicly accessible registry. The trial registers that currently meet all of the ICMJE guidelines can be found at http://www.icmje.org/about-icmje/ .

The trial registration number should be included as the last line of the abstract of the manuscript.

CytoJournal also supports initiatives aimed at improving the reporting of biomedical research. Checklists have been developed for randomized controlled trials (CONSORT http://www.consort-statement.org/index.aspx?o=1065  ), systematic reviews (QUOROM http://www.consort-statement.org/index.aspx?o=1065  ), meta-analyses of observational studies (MOOSE http://www.consort-statement.org/index.aspx?o=1065  ), diagnostic accuracy studies (STARD http://www.consort-statement.org/index.aspx?o=1065  ) and qualitative studies (RATS (see at end). Authors are requested to make use of these when drafting their manuscript and peer reviewers will also be asked to refer to these checklists when evaluating these studies. For authors of systematic reviews, a supplementary file, linked from the Methods section, should reproduce all details concerning the search strategy. For an example of how a search strategy should be presented, see the Cochrane Reviewers' Handbook http://www.cochrane.dk/cochrane/..../r_studies_and_organizing_search_results.htm  .

Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should adhere to the Good Publication Practice guidelines for pharmaceutical companies http://www.gpp-guidelines.org/ , which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.

The involvement of medical writers or anyone else who assisted with the preparation of the manuscript content should be acknowledged, along with their source of funding, as described in the European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications http://www.emwa.org/Mum/EMWAguidelines.pdf  . If medical writers are not listed among the authors, it is important that their role be acknowledged explicitly. We suggest wording such as 'We thank Jane Doe who provided medical writing services on behalf of XYZ Pharmaceuticals Ltd.'

Submission of a manuscript to CytoJournal implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.

Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.



 

Nucleotide sequences

Nucleotide sequences can be deposited with the
DNA Data Bank of Japan (DDBJ)
http://www.ddbj.nig.ac.jp/ ,
European Molecular Biology Laboratory (EMBL/EBI) Nucleotide Sequence Database
http://www.ebi.ac.uk/ , or
GenBank (National Center for Biotechnology Information)
http://www.ncbi.nlm.nih.gov/ .

Protein sequences

Protein sequences can be deposited with SwissProt http://pubchem.ncbi.nlm.nih.gov/ or the Protein Information Resource (PIR) http://pir.georgetown.edu/ .

Structures

Protein structures can be deposited with one of the members of the Worldwide Protein Data Bank http://www.wwpdb.org/  . Nucleic Acids structures can be deposited with the Nucleic Acid Database http://ndbserver.rutgers.edu/  at Rutgers. Crystal structures of organic compounds can be deposited with the Cambridge Crystallographic Data Centre http://www.ccdc.cam.ac.uk/products/csd/deposit/ .

Chemical structures and assays

Structures of chemical substances can be deposited with PubChem Substance http://pubchem.ncbi.nlm.nih.gov/ . Bioactivity screens of chemical substances can be deposited with PubChem BioAssay http://www.ncbi.nlm.nih.gov/sites/entrez?db=pcassay .

Microarray data

Where appropriate, authors should adhere to the standards proposed by the Microarray Gene Expression Data Society http://www.mged.org/  and must deposit microarray data in one of the public repositories, such as ArrayExpress http://www.mged.org/ , Gene Expression Omnibus (GEO) http://www.ncbi.nlm.nih.gov/projects/geo/ or the Center for Information Biology Gene Expression Database (CIBEX) http://cibex.nig.ac.jp/ .

Computional modeling

We encourage authors to prepare models of biochemical reaction networks using the Systems Biology Markup Language http://sbml.org/index.php/Main_Page  and to deposit the model with the BioModels database http://www.ebi.ac.uk/biomodels/  , as well as submitting it as an additional file with the manuscript.

Plasmids

We encourage authors to deposit copies of their plasmids as DNA or bacterial stocks with Addgene http://www.addgene.org/pgvec1  , a non-profit repository, or PlasmID http://plasmid.med.harvard.edu/PLASMID/ , the Plasmid Information Database at Harvard.

CytoJournal endorses the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions http://www.wame.org/resources/policies

»» Preparing main manuscript text Top

File formats

The following word processor file formats are acceptable for the main manuscript document:

·         Microsoft Word (version 2 and above)

·         WordPerfect (version 5 and above)

·         Rich text format (RTF)

·         Portable document format (PDF)

Users of other word processing packages should save or convert their files to RTF before uploading. Many free tools are available which ease this process.

Note that figures must be submitted as separate image files, not as part of the submitted DOC/ PDF file. However, tables are part of the manuscript file. DONOT submit tables with columns and rows as figures. Sketches, different diagrams including bar diagrams and pie charts, algorithms, and flow charts should be submitted as figures.

Article types
CytoJournal considers the following types of articles:

·         Research article - reports of data from original research.

·         Methodology articles - present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available.

·         Case reports - reports of clinical cases that can be educational by discussing a diagnostic dilemma and reporting relatively rare phenomenon or clinical association.

·         Quiz case- Presenting a clinical case to communicate teaching point(s) by presenting it in a quiz format to generate an inquisitive interest for educational progress. Please download the sample CytoJournal Quiz Case from: http://www.cytojournal.com/text.asp?2015/12/1/10/157497. and CytoJournal Quiz Case template from http://www.cytojournal.com/downloads/104h_CytoJournal_Quiz_Case_Blank_Template.pdf

·         Review - comprehensive, authoritative descriptions of any subject within the scope of CytoJournal; these articles are usually written by opinion leaders that have been invited by the Editorial Board.

·         CytoJournal Monograph related review series - comprehensive, authoritative descriptions of any subject within the scope of CytoJournal; these reviews are usually written by opinion leaders that have been invited by the CytoJournal Monograph & Atlas (CMAS) committee and peer-reviewed under leadership of CytoJournal Monograph & Atlas (CMAS) Editorial Board. The peer-review process for these series is not double blind.

·         Editorials - short, focused and opinionated articles on any subject within the scope of CytoJournal; these articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders invited by the Editorial Board.

·         Book reviews - short summaries of the strengths and weaknesses of a book; they should evaluate its overall usefulness to the intended audience.

·         Letters to the editor - short, focused and opinionated brief letter on any subject within the scope of CytoJournal; these articles are usually related to a contemporary issue, written by readers.

Please read the descriptions of each of the article types, choose which is appropriate for your article and structure it accordingly.

Some type of articles (research articles, methodology articles, case reports, quiz cases, review articles, and Cytojournal monograph articles) require at least 3 multiple choice questions for CME. For general guidelines, please use the following manual available free online:

Constructing Written Test Questions For the Basic and Clinical Sciences http://www.nbme.org/PDF/ItemWriting_2003/2003IWGwhole.pdf

If in doubt, your manuscript may be classified as Research, the editorial process will reclassify it as needed.

Manuscript preparation

Manuscripts of the articles submitted to CytoJournal should be divided into the following files and sections:

                I. First page file

·         Title page

·         Competing interests

·         Authors' contributions

·         Acknowledgements  (if any)

II. Article  file

·         Title

·         Abstract

·         Background

·         Methods

·         Results

·         Discussion

·         Conclusions

·         List of abbreviations used (if any)

·         References

·         Figure legends (if any)

·         Tables and captions (if any)

·         Description of additional data files (if any)

You may download different templates First page template (Research), Article file template (Case Report),  Article file template (Research) . For instructions how to use the templates, see below.

The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in the manuscript should be provided, in square brackets and include the corresponding database name; for example, [EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116].

The databases for which we can provide direct links are: EMBL Nucleotide Sequence Database (EMBL), DNA Data Bank of Japan (DDBJ ), GenBank at the NCBI (GenBank), Protein Data Bank (PDB), Protein Information Resource (PIR) and the Swiss-Prot Protein Database (Swiss-Prot).

Title page

This should list the title of the article. The title should include the study design, for example:

A versus B in the treatment of C: a randomized controlled trial

X is a risk factor for Y: a case control study

The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page. The corresponding author should also be indicated.

Abstract

The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Background, the context and purpose of the study; Methods, how the study was performed and statistical tests used; Results, the main findings; Conclusions, brief summary and potential implications.

Please minimize the use of abbreviations and do not cite references in the abstract.

Trial registration, if your research article reports the results of a controlled health care intervention, please list your trial registry, along with the unique identifying number, e.g. Trial registration: Current Controlled Trials ISRCTN73824458. Please note that there should be no space between the letters and numbers of your trial registration number.

Background

The background section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research and its aims. Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field. The section should end with a very brief statement of what is being reported in the article.

Methods

This should include the design of the study, the setting, the type of participants or materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculation if appropriate.

Results and Discussion

The Results and Discussion may be combined into a single section or presented separately. Results of statistical analysis should include, where appropriate, relative and absolute risks or risk reductions, and confidence intervals. The results and discussion sections may also be broken into subsections with short, informative headings.

Conclusions

This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.

List of abbreviations used in the article (in alphabetic order)

If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the competing interests and authors' contributions.

Competing interests

A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.

Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.

When completing your declaration, please consider the following questions:

Financial competing interests

·         In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.

·         Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.

·         Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.

·         Do you have any other financial competing interests? If so, please specify.

Non-financial competing interests

Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify.

If you are unsure as to whether you, or one your co-authors, has a competing interest please discuss it with the editorial office.

Authors' contributions

In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section. All authors declare that they qualify for authorship as defined by ICMJE http://www.icmje.org/ethical_1author.html

An "author" is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.

We suggest the following kind of format (please use initials to refer to each author's contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.

Acknowledgements

Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.

The role of a medical writer must be included in the acknowledgements section, including their source(s) of funding.

Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.

Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

 

 

References

All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.

Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are.

We encourage authors to use a recent version of EndNote (version 5 and above) or Reference Manager (version 10) when formatting their reference list, as this allows references to be automatically extracted. Authors submitting articles in EndNote 5 or higher or Reference Manager 10 format will save ‘30 on the ‘750 (‘985, US$1505) article processing charge. In order to obtain this discount, you should upload the manuscript file containing your EndNote or Reference Manager-formatted bibliography as a .doc file. Please ensure you do not convert to another format (e.g. RTF or PDF). On upload, the discount will be automatically granted and you will receive a confirmation on-screen and by email. You will also be able to preview an HTML version of the extracted references during submission, and we urge authors to check this. EndNote or Reference Manager users should also make sure that any changes made to the reference list are done within their reference management program, rather than by manually editing the formatted bibliography. This is because manually introduced changes will not be picked up in the automatically extracted list.

Examples of the CytoJournal reference style are shown below. Please take care to follow the reference style precisely; references not in the correct style may be retyped, necessitating tedious proofreading.


Download a PowerPoint presentation on common reference styles and using the reference checking facility on the manuscript submission site.

Links

Web links and URLs should be included in the reference list. They should be provided in full, including both the title of the site and the URL, in the following format: The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]

CytoJournal reference style

Article within a journal

1. Shidham VB, Kumar N, Narayan R, Brotzman GL. Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePathTM specimens with review of literature.

CytoJournal 2007,4:7

Free full text is available at: http://www.cytojournal.com/content/4/1/7

PDF at: http://www.cytojournal.com/content/pdf/1742-6413-4-7.pdf

Article within a journal supplement

2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio three-dimensional prediction, secondary structure, and contacts prediction. Proteins 1999, 43(Suppl 3):149-170.

In press article

3. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press.

Published abstract

4. D'Amore K, Varsegi G, Goswami M, Dawson G, Shidham V. Critical evaluation of D2-40 (podoplanin) from two vendors in relation to the differential diagnosis of mesothelial lesions [abstract].Modern Pathology 2008,21:s1A-396A (Abstract no.1657)

Article within conference proceedings

5. Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27.

Book chapter, or article within a book

6. Shidham VB. Respiratory Cytology. In Atkinson Atlas of Diagnostic Cytopathology., Second edition. Edited by Atkinson BF. Philadelphia, PA: W. B. Saunders Company; 2004, 273-356.

Whole issue of journal

7. Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer Res 1998, 10:1-72.

Whole conference proceedings

8. Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996.

Complete book

9. Shidham VB and Atkinson BF. ‘Cytopathologic Diagnosis of Serous Fluids‘ Multi-author book with 15 chapters, Elsevier (W. B. Saunders Company) First edition, 2007.

Monograph or book in a series

10. Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and Tissues. Edited by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, vol 1.]

Book with institutional author

11. Papanicolaou Society of Cytopathology Guidelines for Compliance with Medicare Rules Regarding Ordering of Ancillary Pathologic Tests. Member- ‘Practice Guidelines Task Force‘, The Papanicolaou Society of Cytopathology.


12. Shidham V, Cramer H. Elsheikh TM, Layfield LJ. Papanicolaou Society of Cytopathology Guidelines for Specimen Adequacy and Quality Indicators in Cytopathology Reports. Member- ‘Practice Guidelines Task Force‘, The Papanicolaou Society of Cytopathology.

Link / URL

13. The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]

Microsoft Word template

Although we can accept manuscripts prepared as Microsoft Word, Word Perfect, RTF or PDF files, we have designed a Microsoft Word template that can be used to generate a standard style and format for your article. It can be used if you have not yet started to write your paper, or if it is already written and needs to be put into CytoJournal style.

Download the template from our site (First page general, Manuscript case report, Manuscript general), and save it to your hard drive. Double click the template to open it.

How to use the CytoJournal template

The template consists of a standard set of headings that make up a CytoJournal Research manuscript, along with dummy fragments of body text. Follow these steps to create your manuscript in the standard format:

·         Replace the dummy text for Title, Author details, Institutional affiliations, and the other sections of the manuscript with your own text (either by entering the text directly or by cutting and pasting from your own manuscript document).

·         If there are sections which you do not need, delete them (but check the rest of the Instructions for Authors to see which sections are compulsory).

·         If you need an additional copy of a heading (e.g. for additional figure legends) just copy and paste.

·         For the references, you may either manually enter the references using the reference style given, or use bibliographic software to insert them automatically.

Preparing illustrations and figures

Figures should be provided as separate files and should not be included in the main text of the submitted manuscript. Each figure should comprise only a single file. There is no charge for the use of color and there is no limit to the number of appropriately justified figures.

Formats

The following file formats of max. 1MB size can be accepted online: (How to reduce the image file size)

·         PowerPoint (Each figure must be a single slide in each Powerpoint file)

·         PNG (preferred format for photos or images)

·         JPEG

Figure legends

The legends should be included in the main manuscript text file immediately following the references, rather than being a part of the figure file. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure with detailed legend, up to 300 words. Please keep these ready and open while submitting the manuscript, as you will need these legends to be copy-pasted while submitting/uploading the individual figures.

Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.

Preparing tables

Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, but should be concise.

Smaller tables considered to be integral to the manuscript can be pasted into the end of the document text file, in portrait format (note that tables on a landscape page must be reformatted onto a portrait page or submitted as additional files). These will be typeset and displayed in the final published form of the article. Such tables should be formatted using the 'Table object' in a word processing program to ensure that columns of data are kept aligned when the file is sent electronically for review; this will not always be the case if columns are generated by simply using tabs to separate text. Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines. Commas should not be used to indicate numerical values. Color and shading should not be used.

Style and language

General

Currently, CytoJournal can only accept manuscripts written in English.Spelling should be US English only. Please DONOT use British English or a mixture with other spellings. For information http://en.wikipedia.org/wiki/American_English.

Gene names should be in italic, but protein products should be in plain type.

There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is no restriction on the number of figures, tables or additional files that can be included with each article online. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article.

CytoJournal will not edit submitted manuscripts for style or language; reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting service.

Help and advice on scientific writing

Click here to read

Abbreviations

Abbreviations should be used as sparingly as possible. They can be defined when first used. A list of abbreviations in alphabetic order is encouraged to be provided preceding the acknowledgements and references.

Typography

·         Please use double line spacing.

·         Type the text unjustified, without hyphenating words at line breaks.

·         Use hard returns only to end headings and paragraphs, not to rearrange lines.

·         Capitalize only the first word, and proper nouns, in the title.

·         All pages should be numbered.

·         Use the CytoJournal reference format.

·         Footnotes to text should not be used.

·         Greek and other special characters may be included. If you are unable to reproduce a particular special character, please type out the name of the symbol in full.

·         Please DONOT included author/institution identifiers in the article file which is sent to the reviewers during peer-review process.

Please ensure that all special characters used are embedded in the text, otherwise they will be lost during conversion to PDF.

Units

SI Units should be used throughout (liter and molar are permitted, however).

Technical support for online submission difficulty: systems @ medknow . com

Editorial support with academic questions and other queries: cytojournal @ cytojournal . com

__________________________

Previous file (Before July 6, 2010)

Technical support for online submission difficulty: systems @ medknow . com
Editorial support with academic questions and other queries: cytojournal @ mcw . edu

Submission process

Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf (except in rare cases by the editorial office at the request of the submitting author in rare cases for unforeseen reasons after due documentation). The submitting author takes responsibility for the article during submission and peer review.

To facilitate rapid publication and to minimize administrative costs, CytoJournal accepts only online submission. The submission process is compatible with version 5.5 or later of Internet Explorer and Netscape Navigator, and with most other modern web browsers. It can be used from PC, Mac, or Unix platforms.

Files can be submitted as a batch, or one by one. The submission process can be interrupted at any time - when users return to the site, they can carry on where they left off.

See below for examples of acceptable word processor and graphics file formats. Additional files of any type, such as movies, animations, or original data files, can also be submitted as part of the publication.

Please refer to Submission checklist

Please check the following points before proceeding.

1. Manuscript files

Do you have all the files for the manuscript in an acceptable format?

Main manuscript

Manuscript is split in to the following parts (steps):

 a. First page file (First page general)

  • Use text/rtf/doc/pdf file (Max size 100 KB). This should list the following:

  • The title of the article. The title should preferably include the study design.

  • Author details: The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page.

  • The details of corresponding author should include- e-mail address, mailing address, phone & fax numbers (country & area code).

(In addition please include other details mentioned in the template)

b. Article file  (Manuscript case report, Manuscript general)

  • Use text/rtf/doc/pdf file (Max size 400 KB)  Should contain the Title and text from abstract onwards.

No information which can reveal contributors' identity should be included in this file (e.g. acknowledgement).

c. Figure/video files (must be separate files and should NOT be embedded in the main manuscript).

  • IMAGES: Formats: PNG, TIFF (for photographs and screen dumps), JPEG.

  • FIGURES: Formats PPT

  • VIDEOS: Formats mpg, mpeg, mp4, wmv

CME questions: Some type of articles (research articles, methodology articles, case reports, quiz cases, review articles, and Cytojournal monograph articles) require at least 3 multiple choice questions for CME. For general guidelines, please use the following manual available free online:

Constructing Written Test Questions For the Basic and Clinical Sciences http://www.nbme.org/PDF/ItemWriting_2003/2003IWGwhole.pdf

2. Suggest reviewers: You will have opportunity to suggest reviewers at the end of the manuscript submission.

Please suggest particularly qualified reviewers who have had experience in the subject of the submitted manuscript, but who are not affiliated with the same institutes as the contributor/s.

Please keep their names and e-mail addresses ready to copy-paste.

3. Article Publication Charge (APC)

Are you aware that CytoJournal has APC of US$1500 per article for publication?

This is payable only if the manuscript is accepted after peer review process.

However, there is a good chance that you may be entitled to a discount or will not be required  to pay this yourself.

'CF members' and members of 'CytoJ OA stewards- Plus' are waived of this charge.

APC is subsidized to US $ 500 for members of  CytoJ OA stewards.

Whether paying, qualifying for subsidized/reduced charge, claiming an exemption, or requesting a waiver, please continue with the submission process.

4. Are you one of the authors of this article?

If not, you cannot submit the article on behalf of the authors. The submitting author takes responsibility for the article during submission and peer review.

5. Conditions of submission and CytoJournal Copyright and License Agreement

Do you confirm that all the authors of the manuscript have read and agreed to its content, that readily reproducible materials described in the manuscript will be freely available to any scientist wishing to use them for non-commercial purposes , and that you have ethical approval for any human or animal experimentation (for more information see our Instructions for Authors)? Do you confirm that the manuscript is original, has not already been published in a journal and is not currently under consideration by another journal? By clicking the button below, you are confirming these points and agreeing to these and all other terms of the CytoJournal Copyright and License Agreement, which we suggest you read.

Click here to download the copyright form

Peer review policies

Click here to read

Publication

Once an article is accepted, it is published in CytoJournal immediately as a provisional PDF file. The paper will subsequently be published in both fully browseable web form (HTML), and as a formatted PDF. Tthe HTML of the article will then be available through CytoJournal and PubMed Central, and will also be included in PubMed.

Article-processing charges (APC)

CytoJournal levies an article-processing charge (APC) for every accepted article, to cover the costs incurred by open access publication. Currently the article-processing charge is US$1500.

APC is not applicable for the year 2008. But the generosity of readers and authors to support this ‘open access charter’ of CytoJournal to allow dissemination of scientific peer-reviewed cytopathology literature around the globe would be highly appreciated.

APC is waived for following:

  1. Cytopathology Foundation (CF) members. Please click here to become CF member (US $ 40 / year OR US $ 1000 for life)

  2. All members of organizations/societies/and other entities as ‘CytoJ OA Stewards-Plus’. Please click here to check if your society-organization is ‘CytoJ OA Stewards-Plus’

APC is subsidized to US$ 500 for following:

All members of organizations/societies/and other entities as ‘CytoJ OA Stewards’. Please click here to check if your society-organization has joined as ‘CytoJ OA Stewards’ without any financial obligation to it.

APC may also be waived or subsidized to:
Group with reasonable proof of financial hardship to afford any of the pathways shown above.

Waivers may be granted, particularly for authors from developing countries. For further details, see more information about article-processing charges

Editorial policies

Any manuscript submitted to CytoJournal must not already have been published in another journal or be under consideration by any other journal, although it may have been deposited on a preprint server.

Manuscripts must not have already been published in any journal or other citable form, with the exception that the journal is willing to consider peer-reviewing manuscripts that are translations of articles originally published in another language. In this case, the consent of the journal in which the article was originally published must be obtained and the fact that the article has already been published must be made clear on submission and stated in the abstract.

Manuscripts that are derived from papers presented at conferences can be submitted unless they have been published as part of the conference proceedings in a peer reviewed journal. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. Authors who publish in CytoJournal retain copyright to their work (more information http://creativecommons.org/licenses/by/2.0/ ). Correspondence concerning articles published in CytoJournal is encouraged .

Guideline for duplicate publication as flowchart is at COPE:
http://www.publicationethics.org.uk/flow-charts/cope-flowcharts-optimal.pdf/view


Submission of a manuscript to CytoJournal implies that all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee and Institutional Review Board (IRB) as indicated by local standards and laws.

Research carried out on humans must be in compliance with the <http: www.healthscience.net="" resources="" declaration-of-helsinki"="" target="_blank">Helsinki Declaration http://www.wma.net/e/policy/b3.htm  , and any experimental research on animals must follow internationally recognized guidelines. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body which gave approval, with a reference number where appropriate. Informed consent must also be documented. Manuscripts may be rejected if the editorial office considers that the research has not been carried out within an ethical framework, e.g. if the severity of the experimental procedure is not justified by the value of the knowledge gained.

Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Methods section.

We ask authors of CytoJournal papers to complete a declaration of competing interests, which should be provided as a separate section of the manuscript, to follow the Acknowledgements.

»» Competing interests Top
A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.

Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.

When completing your declaration, please consider the following questions:

Financial competing interests

  • In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.

  • Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.

  • Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.

  • Do you have any other financial competing interests? If so, please specify.

Non-financial competing interests

Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify.
If you are unsure as to whether you, or one your co-authors, has a competing interest please discuss it with the editorial office.

Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'. Much has been written about competing interests (or conflict of interest, as other journals call it) within scientific research, but the following articles provide some background:

R Smith: Beyond conflict of interest. BMJ 1998, 317 :291-292

R Smith: Making progress with competing interests. BMJ 2002, 325 :1375-1376

CD DeAngelis, PB Fontanarosa, A Flanagin: Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001, 286 :89-9

K Morin, H Rakatansky, FA Riddick Jr, LJ Morse, JM O'Bannon 3rd, MS Goldrich, P Ray, M Weiss, RM Sade, MA Spillman: Managing conflicts of interest in the conduct of clinical trials. JAMA 2002, 287 :78-84

For all articles that include information or clinical photographs relating to individual patients, written and signed consent from each patient to publish must also be mailed or faxed to the editorial staff. The manuscript should also include a statement to this effect in the Acknowledgements section, as follows: "Written consent for publication was obtained from the patient or their relative."

CytoJournal supports initiatives to improve the performance and reporting of clinical trials, part of which includes prospective registering and numbering of trials. While there are initiatives to ensure that all clinical trials are registered (most notably the recent statement from the International Committee of Medical Journal Editors - see http://www.icmje.org/about-icmje/ ), we are focusing on controlled trials of healthcare interventions, for now. Authors of protocols or reports of controlled trials of health care interventions must register their trial prior to submission in a suitable publicly accessible registry. The trial registers that currently meet all of the ICMJE guidelines can be found at http://www.icmje.org/about-icmje/ .

The trial registration number should be included as the last line of the abstract of the manuscript.

CytoJournal also supports initiatives aimed at improving the reporting of biomedical research. Checklists have been developed for randomized controlled trials (CONSORT http://www.consort-statement.org/index.aspx?o=1065  ), systematic reviews (QUOROM http://www.consort-statement.org/index.aspx?o=1065  ), meta-analyses of observational studies (MOOSE http://www.consort-statement.org/index.aspx?o=1065  ), diagnostic accuracy studies (STARD http://www.consort-statement.org/index.aspx?o=1065  ) and qualitative studies (RATS (see at end). Authors are requested to make use of these when drafting their manuscript and peer reviewers will also be asked to refer to these checklists when evaluating these studies. For authors of systematic reviews, a supplementary file, linked from the Methods section, should reproduce all details concerning the search strategy. For an example of how a search strategy should be presented, see the Cochrane Reviewers' Handbook http://www.cochrane.dk/cochrane/..../r_studies_and_organizing_search_results.htm  .

Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should adhere to the Good Publication Practice guidelines for pharmaceutical companies http://www.gpp-guidelines.org/ , which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.

The involvement of medical writers or anyone else who assisted with the preparation of the manuscript content should be acknowledged, along with their source of funding, as described in the European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications http://www.emwa.org/Mum/EMWAguidelines.pdf  . If medical writers are not listed among the authors, it is important that their role be acknowledged explicitly. We suggest wording such as 'We thank Jane Doe who provided medical writing services on behalf of XYZ Pharmaceuticals Ltd.'

Submission of a manuscript to CytoJournal implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.

Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.
Nucleotide sequences

Nucleotide sequences can be deposited with the
DNA Data Bank of Japan (DDBJ)
http://www.ddbj.nig.ac.jp/ ,
European Molecular Biology Laboratory (EMBL/EBI) Nucleotide Sequence Database
http://www.ebi.ac.uk/ , or
GenBank (National Center for Biotechnology Information)
http://www.ncbi.nlm.nih.gov/ .

Protein sequences

Protein sequences can be deposited with SwissProt http://pubchem.ncbi.nlm.nih.gov/ or the Protein Information Resource (PIR) http://pir.georgetown.edu/ .

Structures

Protein structures can be deposited with one of the members of the Worldwide Protein Data Bank http://www.wwpdb.org/  . Nucleic Acids structures can be deposited with the Nucleic Acid Database http://ndbserver.rutgers.edu/  at Rutgers. Crystal structures of organic compounds can be deposited with the Cambridge Crystallographic Data Centre http://www.ccdc.cam.ac.uk/products/csd/deposit/ .

Chemical structures and assays

Structures of chemical substances can be deposited with PubChem Substance http://pubchem.ncbi.nlm.nih.gov/ . Bioactivity screens of chemical substances can be deposited with PubChem BioAssay http://www.ncbi.nlm.nih.gov/sites/entrez?db=pcassay .

Microarray data

Where appropriate, authors should adhere to the standards proposed by the Microarray Gene Expression Data Society http://www.mged.org/  and must deposit microarray data in one of the public repositories, such as ArrayExpress http://www.mged.org/ , Gene Expression Omnibus (GEO) http://www.ncbi.nlm.nih.gov/projects/geo/ or the Center for Information Biology Gene Expression Database (CIBEX) http://cibex.nig.ac.jp/ .

Computional modeling

We encourage authors to prepare models of biochemical reaction networks using the Systems Biology Markup Language http://sbml.org/index.php/Main_Page  and to deposit the model with the BioModels database http://www.ebi.ac.uk/biomodels/  , as well as submitting it as an additional file with the manuscript.

Plasmids

We encourage authors to deposit copies of their plasmids as DNA or bacterial stocks with Addgene http://www.addgene.org/pgvec1  , a non-profit repository, or PlasmID http://plasmid.med.harvard.edu/PLASMID/ , the Plasmid Information Database at Harvard.

CytoJournal endorses the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions http://www.wame.org/resources/policies

File formats

The following word processor file formats are acceptable for the main manuscript document:

  • Microsoft Word (version 2 and above)

  • WordPerfect (version 5 and above)

  • Rich text format (RTF)

  • Portable document format (PDF)

Users of other word processing packages should save or convert their files to RTF before uploading. Many free tools are available which ease this process.

Note that figures must be submitted as separate image files, not as part of the submitted DOC/ PDF file.

Article types
CytoJournal considers the following types of articles:

  • Research article - reports of data from original research.

  • Methodology articles - present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available.

  • Case reports - reports of clinical cases that can be educational by discussing a diagnostic dilemma and reporting relatively rare phenomenon or clinical association.

  • Quiz case- Presenting a clinical case to communicate teaching point(s) by presenting it in a quiz format to generate an inquisitive interest for educational progress.

  • Review - comprehensive, authoritative descriptions of any subject within the scope of CytoJournal; these articles are usually written by opinion leaders that have been invited by the Editorial Board.

  • CytoJournal Monograph related review series - comprehensive, authoritative descriptions of any subject within the scope of CytoJournal; these reviews are usually written by opinion leaders that have been invited by the CytoJournal Monograph committee and peer-reviewed under leadership of CytoJournal Monograph Editorial Board.

  • Editorials - short, focussed and opinionated articles on any subject within the scope of CytoJournal; these articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders invited by the Editorial Board.

  • Book reviews - short summaries of the strengths and weaknesses of a book; they should evaluate its overall usefulness to the intended audience.

  • Letters to the editor - short, focussed and opinionated brief letter on any subject within the scope of CytoJournal; these articles are usually related to a contemporary issue, written by readers.

Please read the descriptions of each of the article types, choose which is appropriate for your article and structure it accordingly.

Some type of articles (research articles, methodology articles, case reports, quiz cases, review articles, and Cytojournal monograph articles) require at least 3 multiple choice questions for CME. For general guidelines, please use the following manual available free online:

Constructing Written Test Questions For the Basic and Clinical Sciences http://www.nbme.org/PDF/ItemWriting_2003/2003IWGwhole.pdf

If in doubt, your manuscript should be classified as Research, the structure for which is described below.

Manuscript sections for Research articles

Manuscripts for Research articles submitted to CytoJournal should be divided into the following sections:

You can download a template (First page general, Manuscript case report, Manuscript general)  for your article. For instructions on use, see below.

The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in the manuscript should be provided, in square brackets and include the corresponding database name; for example, [EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116].

The databases for which we can provide direct links are: EMBL Nucleotide Sequence Database (EMBL), DNA Data Bank of Japan (DDBJ ), GenBank at the NCBI (GenBank), Protein Data Bank (PDB), Protein Information Resource (PIR) and the Swiss-Prot Protein Database (Swiss-Prot).

Title page

This should list the title of the article. The title should include the study design, for example:

A versus B in the treatment of C: a randomized controlled trial

X is a risk factor for Y: a case control study

The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page. The corresponding author should also be indicated.

Abstract

The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Background, the context and purpose of the study; Methods, how the study was performed and statistical tests used; Results, the main findings; Conclusions, brief summary and potential implications.

Please minimize the use of abbreviations and do not cite references in the abstract.

Trial registration, if your research article reports the results of a controlled health care intervention, please list your trial registry, along with the unique identifying number, e.g. Trial registration: Current Controlled Trials ISRCTN73824458. Please note that there should be no space between the letters and numbers of your trial registration number.

Background

The background section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research and its aims. Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field. The section should end with a very brief statement of what is being reported in the article.

Methods

This should include the design of the study, the setting, the type of participants or materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculation if appropriate.

Results and Discussion

The Results and Discussion may be combined into a single section or presented separately. Results of statistical analysis should include, where appropriate, relative and absolute risks or risk reductions, and confidence intervals. The results and discussion sections may also be broken into subsections with short, informative headings.

Conclusions

This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.

List of abbreviations used in the article (in alphabetic order)

If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the competing interests and authors' contributions.

»» Competing interests Top
A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.

Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.

When completing your declaration, please consider the following questions:

Financial competing interests

  • In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.

  • Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.

  • Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.

  • Do you have any other financial competing interests? If so, please specify.

Non-financial competing interests

Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify.

If you are unsure as to whether you, or one your co-authors, has a competing interest please discuss it with the editorial office.

Authors' contributions

In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.

An "author" is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.

We suggest the following kind of format (please use initials to refer to each author's contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.

Acknowledgements

Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.

The role of a medical writer must be included in the acknowledgements section, including their source(s) of funding.

Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.

Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

References

All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.

Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are.

We encourage authors to use a recent version of EndNote (version 5 and above) or Reference Manager (version 10) when formatting their reference list, as this allows references to be automatically extracted. Authors submitting articles in EndNote 5 or higher or Reference Manager 10 format will save ‘30 on the ‘750 (‘985, US$1505) article processing charge. In order to obtain this discount, you should upload the manuscript file containing your EndNote or Reference Manager-formatted bibliography as a .doc file. Please ensure you do not convert to another format (e.g. RTF or PDF). On upload, the discount will be automatically granted and you will receive a confirmation on-screen and by email. You will also be able to preview an HTML version of the extracted references during submission, and we urge authors to check this. EndNote or Reference Manager users should also make sure that any changes made to the reference list are done within their reference management program, rather than by manually editing the formatted bibliography. This is because manually introduced changes will not be picked up in the automatically extracted list.

Examples of the CytoJournal reference style are shown below. Please take care to follow the reference style precisely; references not in the correct style may be retyped, necessitating tedious proofreading.


Download a PowerPoint presentation on common reference styles and using the reference checking facility on the manuscript submission site.

Links

Web links and URLs should be included in the reference list. They should be provided in full, including both the title of the site and the URL, in the following format: The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]

CytoJournal reference style

Article within a journal

1. Shidham VB, Kumar N, Narayan R, Brotzman GL. Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePathTM specimens with review of literature.

CytoJournal 2007,4:7

Free full text is available at: http://www.cytojournal.com/content/4/1/7

PDF at: http://www.cytojournal.com/content/pdf/1742-6413-4-7.pdf

Article within a journal supplement

2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio three-dimensional prediction, secondary structure, and contacts prediction. Proteins 1999, 43(Suppl 3):149-170.

In press article

3. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press.

Published abstract

4. D'Amore K, Varsegi G, Goswami M, Dawson G, Shidham V. Critical evaluation of D2-40 (podoplanin) from two vendors in relation to the differential diagnosis of mesothelial lesions [abstract].Modern Pathology 2008,21:s1A-396A (Abstract no.1657)

Article within conference proceedings

5. Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27.

Book chapter, or article within a book

6. Shidham VB. Respiratory Cytology. In Atkinson Atlas of Diagnostic Cytopathology., Second edition. Edited by Atkinson BF. Philadelphia, PA: W. B. Saunders Company; 2004, 273-356.

Whole issue of journal

7. Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer Res 1998, 10:1-72.

Whole conference proceedings

8. Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996.

Complete book

9. Shidham VB and Atkinson BF. ‘Cytopathologic Diagnosis of Serous Fluids‘ Multi-author book with 15 chapters, Elsevier (W. B. Saunders Company) First edition, 2007.

Monograph or book in a series

10. Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and Tissues. Edited by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, vol 1.]

Book with institutional author

11. Papanicolaou Society of Cytopathology Guidelines for Compliance with Medicare Rules Regarding Ordering of Ancillary Pathologic Tests. Member- ‘Practice Guidelines Task Force‘, The Papanicolaou Society of Cytopathology.


12. Shidham V, Cramer H. Elsheikh TM, Layfield LJ. Papanicolaou Society of Cytopathology Guidelines for Specimen Adequacy and Quality Indicators in Cytopathology Reports. Member- ‘Practice Guidelines Task Force‘, The Papanicolaou Society of Cytopathology.

Link / URL

13. The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]

Microsoft Word template

Although we can accept manuscripts prepared as Microsoft Word, Word Perfect, RTF or PDF files, we have designed a Microsoft Word template that can be used to generate a standard style and format for your article. It can be used if you have not yet started to write your paper, or if it is already written and needs to be put into CytoJournal style.

Download the template from our site (First page general, Manuscript case report, Manuscript general), and save it to your hard drive. Double click the template to open it.

How to use the CytoJournal template

The template consists of a standard set of headings that make up a CytoJournal Research manuscript, along with dummy fragments of body text. Follow these steps to create your manuscript in the standard format:

  • Replace the dummy text for Title, Author details, Institutional affiliations, and the other sections of the manuscript with your own text (either by entering the text directly or by cutting and pasting from your own manuscript document).

  • If there are sections which you do not need, delete them (but check the rest of the Instructions for Authors to see which sections are compulsory).

  • If you need an additional copy of a heading (e.g. for additional figure legends) just copy and paste.

  • For the references, you may either manually enter the references using the reference style given, or use bibliographic software to insert them automatically.

Preparing illustrations and figures

Figures should be provided as separate files and should not be included in the main text of the submitted manuscript. Each figure should comprise only a single file. There is no charge for the use of color.

Formats

The following file formats of max. 1MB size can be accepted online: (How to reduce the image file size)

  • PNG (preferred format for photos or images)

  • PowerPoint (Each figure must be a single slide in each Powerpoint file)

  • JPEG

Figure legends

The legends should be included in the main manuscript text file immediately following the references, rather than being a part of the figure file. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure with detailed legend, up to 300 words.

Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.

Preparing tables

Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, but should be concise.

Smaller tables considered to be integral to the manuscript can be pasted into the end of the document text file, in portrait format (note that tables on a landscape page must be reformatted onto a portrait page or submitted as additional files). These will be typeset and displayed in the final published form of the article. Such tables should be formatted using the 'Table object' in a word processing program to ensure that columns of data are kept aligned when the file is sent electronically for review; this will not always be the case if columns are generated by simply using tabs to separate text. Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines. Commas should not be used to indicate numerical values. Color and shading should not be used.

Style and language

General

Currently, CytoJournal can only accept manuscripts written in English.Spelling should be US English only. Please DONOT use British English or a mixture with other spellings. For information http://en.wikipedia.org/wiki/American_English.

Gene names should be in italic, but protein products should be in plain type.

There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is no restriction on the number of figures, tables or additional files that can be included with each article online. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article.

CytoJournal will not edit submitted manuscripts for style or language; reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting service.

Help and advice on scientific writing

Click here to read

Abbreviations

Abbreviations should be used as sparingly as possible. They can be defined when first used or a list of abbreviations can be provided preceding the acknowledgements and references.

Typography

  • Please use double line spacing.

  • Type the text unjustified, without hyphenating words at line breaks.

  • Use hard returns only to end headings and paragraphs, not to rearrange lines.

  • Capitalize only the first word, and proper nouns, in the title.

  • All pages should be numbered.

  • Use the CytoJournal reference format.

  • Footnotes to text should not be used.

  • Greek and other special characters may be included. If you are unable to reproduce a particular special character, please type out the name of the symbol in full.

    Please ensure that all special characters used are embedded in the text, otherwise they will be lost during conversion to PDF.

Units

SI Units should be used throughout (liter and molar are permitted, however).

Technical support for online submission difficulty: systems @ medknow . com

Editorial support with academic questions and other queries: cytojournal @ cytojournal . com


 

Top

  Site Map | Copyright and Disclaimer
© 2007 - CytoJournal | Published by Cytopathology Foundation Inc with Wolters Kluwer - Medknow
New version online since 1st July '08
Open Access